Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer under Italian finance probe over alleged $1.2B profits offshoring
Pfizer under Italian finance probe over alleged $1.2B profits offshoring
Fierce Pharma
Pfizer
Italy
taxes
offshoring
Flag link:
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
Endpoints
Vaxcyte
vaccines
VAX-24
pneumococcal disease
Pfizer
Prevnar 20
clinical trials
Flag link:
Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report
Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report
Fierce Pharma
Pfizer
Ireland
drug manufacturing
Flag link:
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
Endpoints
Pfizer
BioNTech
payers
vaccines
COVID-19
Flag link:
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
BioSpace
Erasca
Pfizer
ERAS-007
Ibrance
colorectal cancer
Flag link:
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Fierce Pharma
Pfizer
Pharma CEOs
Albert Bourla
drug launches
COVID-19
vaccines
Flag link:
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
AM-Pharma
clinical trials
kidney injury
Pfizer
Flag link:
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Nucleome Therapeutics
funding
precision medicine
autoimmune diseases
Pfizer
JNJ
Merck KGaA
autoimmune disease
Flag link:
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Pfizer
Supreme Court
kickbakcs
tafamidis
copays
Vyndaqel
Flag link:
FDA Review: Phanes, Pfizer, GSK and More
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Flag link:
Few safe havens surface in another down quarter for biopharma
Few safe havens surface in another down quarter for biopharma
EP Vantage
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Flag link:
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
Flag link:
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Yahoo/Businesswire
Pfizer
BioNTech
clinical trials
COVID-19
vaccines
boosters
bivalent boosters
Flag link:
FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID vaccines for booster doses in younger age groups
FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID vaccines for booster doses in younger age groups
Pharma Live
FDA
Pfizer
Moderna Therapeutics
BioNTech
vaccines
boosters
bivalent boosters
COVID-19
pediatric
Flag link:
FWIW, Pfizer exec denies company negotiated vaccine deal with Europe via text messages
FWIW, Pfizer exec denies company negotiated vaccine deal with Europe via text messages
Fierce Pharma
Pfizer
Pharma CEOs
Albert Bourla
vaccines
COVID-19
Europe
Flag link:
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Andera Partners
funding
life sciences
startups
Pfizer
Novo Nordisk
Europe
venture capital
Flag link:
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
Fierce Pharma
Pfizer
BioNTech
MRNA
Australia
COVID-19
Flag link:
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Pfizer
M&A
Global Blood Therapeutics
Biohaven
Flag link:
No big bang for biopharma buyouts
No big bang for biopharma buyouts
EP Vantage
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
Flag link:
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Pfizer
Biohaven
migraines
epilepsy
Flag link:
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »